Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma
Open Access
- 25 September 2015
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 10 (1) , 1-9
Abstract
To investigate the relationship of KAI1/CD82, CD44, matrix metalloproteinase 7 (MMP7) and β-catenin, and examine its association with clinicopathological features, metastasis and prognosis in colorectal carcinoma (CRC). Immunohistochemical (IHC) analysis was used to detect the expression of KAI1/CD82, CD44, MMP7 and β-catenin in 174 archival surgical specimens of human CRC. Furthermore, clinicopathological features such as age, sex and so on were also collected retrospectively. CD44, MMP7 and β-catenin expression was positively associated with distant metastasis, lymph node metastasis and tumor-node-metastasis (TNM) stage. However, decreased KAI1/CD82 expression correlated significantly with distant metastasis, lymph node metastasis and TNM stage. KAI1/CD82 expression showed a negative correlation with CD44, MMP7 and β-catenin. Furthermore, β-catenin expression showed a positive correlation with CD44 and MMP7. Multivariate logistic regression analysis showed that KAI1/CD82 and β-catenin expression were significantly associated with lymph node metastasis and KAI1/CD82 was significantly associated with distant metastasis. Kaplan-Meier analysis revealed that CD44, MMP7 and β-catenin expression was negatively correlated with overall survival (OS), while KAI1/CD82 expression was positively correlated with OS. Low KAI1/CD82 expression and high expression of CD44, MMP7 and β-catenin was associated with a poor prognosis in CRC. Multivariate Cox regression analysis indicated that the expression of KAI1/CD82, MMP7 and β-catenin were independent predictors of OS in CRC. The expression of KAI1/CD82, CD44, MMP7 and β-catenin is related to tumor metastasis and prognosis in CRC. Combined detection of these factors may be of significant value in predicting the prognosis and metastasis in CRC patients.Keywords
Funding Information
- National Natural Science Foundation of China (CN) (81402514)
- Natural Science Foundation of Anhui Province (CN) (1408085QH166)
- Natural Science Foundation of Bengbu Medical College (BYKY1417ZD)
This publication has 45 references indexed in Scilit:
- β-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-AnalysisPLOS ONE, 2013
- CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cellsInternational Journal of Oncology, 2012
- Rethinking the metastatic cascade as a therapeutic targetNature Reviews Clinical Oncology, 2011
- Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signalingJournal of Cell Biology, 2010
- Expression of standard CD44 in human colorectal carcinoma: Association with prognosisPathology International, 2009
- Expression of the cell‐cell adhesion molecule β‐catenin in colorectal carcinomas and their metastasesAPMIS, 2008
- KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell lineBiochemical and Biophysical Research Communications, 2006
- Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancersInternational Journal of Cancer, 2000
- Expression of CD44 and Variant Proteins in Human Colorectal Cancer and Its Relevance for PrognosisScandinavian Journal of Gastroenterology, 1998
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995